BCR-ABL-IN-9

SKU: orb2695561

Description

BCR-ABL-IN-9 (Compound B1) is a potent, covalent BCR-ABL kinase inhibitor with an IC50 of 1.2 nM. It achieves sustained target suppression and demonstrates anticancer activity, supporting its use in vitro and in vivo for research on BCR-ABL-driven malignancies like chronic myeloid leukemia.

Research Area

Cardiovascular Research, Signal Transduction

Key Properties

• MW: 388.42
• Formula: C₂₂H₂₀N₄O₃
• Target: Bcr-Abl

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

20857278